Its synaptic localisation and correlation with disease progression indicates that NPTX2 decreases probably reflect synaptic dysfunction or loss, providing novel opportunities for in vivo monitoring of synaptic integrity in genetic FTD. Here, NPTX2 is linked to frontotemporal dementia.